Antibiotic brings some improvement in fragile X syndrome, reports JDBP
Sunday, April 8, 2012 ยท Posted by Wolters Kluwer Health
This preliminary clinical trial shows small but significant benefits of minocycline in children with FXS. Other treatments for FXS are being investigated, including a new class of drugs called mGluR5 inhibitors. However, minocycline is the only targeted FXS treatment that is currently available by prescription. Because of its long history of use, the side effects and safety characteristics of minocycline are well known.